Inflammation enhanced brain-derived neurotrophic factor-induced suppression of the voltage-gated potassium currents in small-diameter trigeminal ganglion neurons projecting to the trigeminal nucleus interpolaris/caudalis transition zone

Neuroscience

Volumn 261, Issue , 2014, Pages 223-231

  Takeda, M ^a   Takahashi, M ^a   Matsumoto, S ^a  

^a NIPPON DENTAL UNIVERSITY   (Japan)

Author keywords

BDNF; Hyperalgesia; Inflammation; Trigeminal ganglion; TrkB

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; K 252A; VOLTAGE GATED POTASSIUM CHANNEL;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LABELING; CELL SIZE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG MECHANISM; HYPERALGESIA; INNERVATION; MALE; MYOSITIS; NERVE CELL; NERVE CELL EXCITABILITY; NEUROMODULATION; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; SKELETAL MUSCLE; TRIGEMINAL NUCLEUS; TRIGEMINAL NUCLEUS CAUDALIS TRANSITION ZONE; TRIGEMINAL NUCLEUS INTERPOLARIS TRANSITION ZONE; TRIGEMINUS GANGLION; VOLTAGE CLAMP TECHNIQUE;

BDNF; HYPERALGESIA; INFLAMMATION; TRIGEMINAL GANGLION; TRKB; VOLTAGE-GATED K(+) CURRENTS;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CARBAZOLES; ENZYME INHIBITORS; FREUND'S ADJUVANT; HYPERALGESIA; INDOLE ALKALOIDS; INFLAMMATION; MALE; MASSETER MUSCLE; MEMBRANE POTENTIALS; NEURONS; POTASSIUM; POTASSIUM CHANNELS, VOLTAGE-GATED; RATS; RATS, WISTAR; TOUCH; TRIGEMINAL GANGLION;

EID: 84893017641     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.12.048     Document Type: Article

References (46)

1. Barde Y.-A. Neurotrophin channels excitement. Nature 2002, 419:683-684.
2. Buldyrev I., Tanner N.M., Hsieh H.Y., Dodd E.G., Nguyen L., Balkowiec A. Calcitonin gene-related peptide enhances release of native brain-derived neurotorophic factor from trigeminal ganglion neurons. J Neurochem 2006, 99:1338-1350.
3. + channel activity in primary sensory neurons in painful diabetic neuropathy: role of brain derived neurotrophic factor. J Neurochem 2010, 114:1460-1475.
4. Cao X.-H., Chen S.-R., Li L., Pan H.-L. Nerve injury increases brain-derived neurotrophic factor levels to suppress BK channel activity in primary neurons. J Neurochem 2012, 12:944-953.
5. Chao M.V. Neurotrophins and their receptors: a convergence point for many signaling pathways. Nat Neurosci 2003, 4:299-309.
6. Everill B., Kocsis J.D. Reduction in potassium currents in identified cutaneous afferent dorsal root ganglion neuron after axotomy. J Neurophysiol 1999, 82:700-708.
7. Ficker E., Heinemann U. Slow and fast transient potassium currents in cultured rat hippocampus cells. J Physiol 1992, 445:431-455.
8. Hara N., Takeda M., Takahashi M., Matsumoto S. Iontophoretic application of an A-type potassium channel blocker into the trigeminal ganglia enhances the excitability of Aδ- and C-neurons innervating the temporomandibular joint in rats. Neurosci Res 2012, 74:216-222.
9. Harper A.A., Lawson S.N. Conduction velocity is related to morphological cell type in rat dorsal root ganglion neurones. J Physiol 1985, 359:31-46.
10. Hille B. Potassium channels and chloride channels. Ion channels of excitable membranes 2001, 134-167. Sinauer Associates, Sunderland, Massachusetts. 3rd ed. B. Hille (Ed.).
11. Hirano K., Kuratani K., Fujiyoshi M., Tashiro N., Hayashi E., Kinoshita M. Kv7.2-7.5 voltage-gated potassium channel (KCNQ2-5) opener, rtigabine, reduces capsaicin-induced visceral pain in mice. Neurosci Lett 2007, 413:159-162.
12. Ichikawa H., Fukunaga T., Jin H.W., Fujita M., Takano-Yamamoto T., Sugimoto T. VR1-, VRL-1- and P2X3 receptor-immunoreactive innervation of the rat temporomandibular joint. Brain Res 2004, 1008:131-136.
13. Lawson K. Potassium channels as targets for the management of pain. CNS Agents Med Chem 2006, 6:119-128.
14. Li H.S., Xu X.Z., Montell C. Activation of TRPC3-dependent cation current through the neurotrophin BDNF. Neuron 1999, 24:261-273.
15. 2+ dependence in rat trigeminal ganglion cells. J Neurophysiol 1996, 75:1503-1514.
16. Ma Q.P. Expression of capsaicin receptor (VR1) by myelinated primary afferent neurons in rats. Neurosci Lett 2002, 319:87-90.
17. Matayoshi S., Jiang N., Katafuch T., Kog K., Furue H., Yasaka T., Nakatsuka T., Zhou X.-F., Kawasaki Y., Tanaka N., Yoshimura M. Actions of brain-derived neurotrophic factor on spinal nociceptive transmission during inflammation in the rat. J Physiol 2005, 569:685-695.
18. Mathie A., Woolton J.R.A., Watkins C.S. Voltage-activated potassium channels in mammalian neurons and their block by novel pharmacological agents. Gen Pharmacol 1998, 30:13-14.
19. Obata K., Noguchi K. BDNF in sensory neurons and chronic pain. Neurosci Res 2006, 55:1-10.
20. Paxinos G., Watson C. The rat brain in stereotaxic coordinates, compact 2009, Academic Press, Sydney. 6th ed.
21. Peace R.J., Duchen M.R. Differential expression of membrane currents in dissociated mouse primary sensory neurons. Neuroscience 1994, 63:1041-1056.
22. Pezet S., Malcangio M., McMahorn S.B. BDNF: a neuromodulator in nociceptive pathways?. Brain Res Rev 2002, 40:240-249.
23. Puil E., Miura R.M., Spigelman I. Consequence of 4-aminopyridine applications to trigeminal root ganglion neurons. J Neurophysiol 1989, 62:810-820.
24. Rasband M.N., Park E.W., Vanderah T.W., Lai J., Porreca F., Trimmer J.S. Distinct potassium channels on pain-sensing neurons. Proc Natl Acad Sci U S A 2001, 8:13373-13378.
25. Ren K., Dubner R. Pain facilitation and activity-dependent plasticity in pain modulatory circuitry: role of BDNF-trkB signaling and NMDA receptors. Mol Neurobiol 2007, 35:224-235.
26. Ren K., Dubner R. The role of trigeminal interpolaris-caudalistransition zone in persistent orofacial pain. Int Rev Neurobiol 2011, 97:207-225.
27. Rose C.R., Blum R., Kafitz K.W., Kovalchuk Y., Konnerth From modulator to mediator: rapid effects of BDNF on ion channels. Bioassays 2004, 26:1185-1194.
28. Sugiyo S., Takemura M., Dubner R., Ren K. Trigeminal transition zone/rostral ventral medial medulla connections and facilitation of orofacial hyperalgesia after masseter muscle inflammation in rats. J Comp Neurol 2005, 493:510-523.
29. Takeda M., Tanimoto T., Ikeda M., Nasu M., Kadoi J., Shima Y., Ohta H., Matsumoto S. Temporomandibular joint inflammation potentiates the excitability of trigeminal root ganglion neurons innervating the facial skin in rats. J Neurophysiol 2005, 93:2723-2738.
30. 1 spinal neurons responding to tooth-pulp stimulation in rats. Exp Brain Res 2005, 160:107-117.
31. Takeda M., Tanimoto T., Ikeda M., Nasu M., Kadoi J., Yoshida S., Matsumoto S. Enhanced excitability of rat trigeminal root ganglion neurons via decrease in A-type potassium currents following temporomandibular joint inflammation. Neuroscience 2006, 138:621-663.
32. Takeda M., Kadoi J., Takahashi M., Nasu M., Matsumoto S. Somatostatin inhibits the excitability of rat small-diameter trigeminal ganglion neurons that innervate nasal mucosa and project to upper cervical dorsal horn via activation of somatostatin 2a receptor. Neuroscience 2007, 148:744-756.
33. Takeda M., Kitagawa J., Takahashi M., Matsumoto S. Activation of interleukin-1β receptor suppresses the voltage-gated potassium currents in the small-diameter trigeminal ganglion neurons following peripheral inflammation. Pain 2008, 139:594-602.
34. Takeda M., Kitagawa J., Takahashi M., Iwata K., Mastsumoto S. Glial cell line-derived neurotrophic factor acutely modulates the excitability of rat small-diameter trigeminal ganglion neurons innervating facial skin. Brain Behav Immun 2010, 24:72-82.
35. Takeda M., Takahashi M., Kitagawa J., Kanazawa T., Nasu M., Matsumoto S. Brain-derived neurotrophic factor enhances the excitability of small-diameter trigeminal ganglion neurons projecting to the trigeminal nucleus interpolaris/caudalis transition zone following masseter muscle inflammation. Mol Pain 2013, 9:49.
36. Thompson S.W., Bennett D.L., Ker B.J., Bradbury E.J., McMahon S.B. Brain-derived neurotrophic factor is an endogenous modulator of nociceptive responses in the spinal cord. Proc Natl Acad Sci U S A 1999, 96:7714-7718.
37. Uchida H., Sasaki K., Ma L., Ueda H. Neuron-restrictive silencer factor causes epigenetic silencing of Kv4.3 gene after peripheral nerve injury. Neuroscience 2010, 166:1-4.
38. Ueda H. Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms. Phamacol Ther 2006, 109:57-77.
39. Wetmore C., Olson L. Neuronal and non neuronal expression of neurotrophins and their receptor in sensory and sympathetic ganglia suggest new intracellular trophic interactions. J Comp Neurol 1995, 353:143-159.
40. + channels of dorsal root ganglion neurons by the long-duration anesthetic butamben. J Pharmacol Exp Ther 2005, 314:1177-1186.
41. + currents and action potentials in tetrodotoxin-resistant adult rat trigeminal ganglion neurons. J Pharmacol ExpTher 2005, 314:437-445.
42. Yoshimura N., de Groat W.C. Increased excitability of afferent neurons innervating rat urinary bladder inflammation. J Neurosci 1999, 19:4644-4653.
43. Youssoufian M., Walmsley B. Brain-derived neurotrophic factor modulates cell excitability in the mouse medial bucleus of trapezoid body. Eur J Nuerosci 2007, 25:1647-1652.
44. Zhang Y.H., Chi X.X., Nicol G.D. Brain-derived neurotrophic factor enhances the excitability of rat sensory neurons through activation of the p75 neurotrophin receptor and the sphingomyelin pathway. J Physiol 2008, 586:3113-3127.
45. Zhou X.F., Rush R.A. Endogenous brain-derived neurotrophic factor is anterogradely transported primary sensory neurons. Neuroscience 1996, 4:945-953.
46. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.